Intranasal sumatriptan for prevention of post-ECT headaches.
White
Paul F
PF
Purdue
Lisa
L
Downing
Michael
M
Thornton
Larry
L
D000281:Administration, Intranasal; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D006261:Headache / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use*; D016896:Treatment Outcome
D017366:Serotonin Receptor Agonists; D018170:Sumatriptan